Recently I have seen in one of the article in New England Journal of Medicine that DPP-4 inhibitors or better to say "incretins based inhibitors" can increase the susceptibility towards cancer and that has been shown in post market surveillance?
I have highlighted the statement that I got in New England Journal of Medicine and also attaching the concerning article.
Please find the attachment